Patent: 7,901,666
✉ Email this page to a colleague
Summary for Patent: 7,901,666
Title: | Nanoparticles for protein drug delivery |
Abstract: | The invention discloses a pharmaceutical composition for treating a subject comprising two or more bioactive nanoparticles, thus treating the subject by co-administering the bioactive nanoparticles to the subject, wherein a first and a second bioactive nanoparticles comprise a shell portion that is dominated by positively charged chitosan, a core portion that contains negatively charged substrate, and at least a first bioactive agent in the first nanoparticle and a second bioactive agent in the second nanoparticle. |
Inventor(s): | Sung; Hsing-Wen (Hsinchu, TW), Tu; Hosheng (Newport Beach, CA) |
Assignee: | GP Medical, Inc. (Newport Beach, CA) National Tsing Hua University (Hsinchu, TW) |
Application Number: | 12/455,339 |
Patent Claims: | see list of patent claims |
Details for Patent 7,901,666
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Glaxosmithkline Llc | TANZEUM | albiglutide | For Injection | 125431 | 04/15/2014 | ⤷ Try a Trial | 2025-01-04 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |